Skip to main navigation Skip to search Skip to main content

The antidiabetic drug troglitazone protects against PrP (106-126)-induced neurotoxicity via the PPARγ-autophagy pathway in neuronal cells

Research output: Contribution to journalJournal articlepeer-review

Original languageKorean
JournalMolecular Medicine Reports
StatePublished - 2021.06.1

Cite this